(Q44867008)

7 December 2017

title

Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches (English)

1 reference

7 December 2017

1 reference

Phillip C Jobe

1

1 reference

7 December 2017

publication date

1 January 2004

1 reference

Clinical EEG and Neuroscience

7 December 2017

published in

1 reference

7 December 2017

volume

35

1 reference

7 December 2017

issue

1

1 reference

7 December 2017

page(s)

53-68

1 reference

Antidepressants and seizures: clinical anecdotes overshadow neuroscience

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Imipramine in absence and myoclonic-astatic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

21 January 2018

Imipramine in Epilepsy

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Effect of psychotropic medications on seizure control in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Noradrenergic abnormalities in the genetically epilepsy-prone rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Further evidence of anticonvulsant role for 5‐hydroxytryptamine in genetically epilepsy‐prone rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Acute antidepressant effect following pulse loading with intravenous and oral clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: a synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Effect of alterations in extracellular norepinephrine on adrenoceptors: a microdialysis study in freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Therapeutic use of sleep deprivation in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Sleep deprivation in depression: what do we know, where do we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Onset of action of antidepressants: results of different analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Acceleration and augmentation strategies for treating bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

The pharmacology of putative early-onset antidepressant strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

The effect of ipsapirone and S(-)-pindolol on dopamine release in rat striatum and nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-H

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

How long should pindolol be associated with paroxetine to improve the antidepressant response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Mitchell B. Balter Award--1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Carbamazepine-induced release of serotonin from rat hippocampus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Dual monoamine modulation for improved treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Repeated administration of milnacipran induces rapid desensitization of somatodendritic 5-HT1A autoreceptors but not postsynaptic 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Meta-analytical studies on new antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Acute SSRI administration affects the processing of social cues in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Prenatal and postnatal flavor learning by human infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Affect and memory in depression: evidence of better delayed recall of positive than negative affect words.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Activation of post-synaptic 5-HT(1A) receptors in the dorsal hippocampus prevents learned helplessness development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Evaluating how placebos produce change. Logical and causal traps and understanding cognitive explanatory mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

What are the main methodological problems in the estimation of placebo effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Placebo response in studies of major depression: variable, substantial, and growing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Placebo effects in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

The uncontrollable placebo effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

How the doctor's words affect the patient's brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Dopamine release in human ventral striatum and expectation of reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Effects of cocaine context on NAcc dopamine and behavioral activity after repeated intravenous cocaine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3s): an in vitro study on the locus coeruleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Morphological deficits in noradrenergic neurons in GEPR-9s stem from abnormalities in both the locus coeruleus and its target tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Novel therapeutic approaches beyond the serotonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Alpha-1 adrenoceptors are decreased in human epileptic foci

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Amygdala kindling of forebrain seizures and the occurrence of brainstem seizures in genetically epilepsy-prone rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Angular bundle kindling is accelerated in rats with a genetic predisposition to acoustic stimulus-induced seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

The development of kindled seizures is accelerated in the genetically epilepsy-prone rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Mechanisms underlying epileptogenesis in cortical malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Epileptogenesis and the immature brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

21 January 2018

GABA and epileptogenesis

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Experimental epileptogenesis: Kindling-induced epilepsy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Kindling epileptogenesis in orbital and mesial frontal cortical areas of subhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Sensitization and kindling phenomena in mood, anxiety, and obsessive-compulsive disorders: the role of serotonergic mechanisms in illness progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

On the impact of episode sensitization on the course of recurrent affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Do the epilepsies, pain syndromes, and affective disorders share common kindling-like mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Are there specific anatomical and/or transmitter systems (cortical or subcortical) that should be targeted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Distribution of seizure precipitants among epilepsy syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Stress reactivity in bipolar patients and its relation to prior history of disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Extracellular concentrations of catecholamines and amino acids in the dorsomedial hypothalamus of kindled rats. A microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

A damage to locus coeruleus neurons converts sporadic seizures into self-sustaining limbic status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Pharmacoresistance: modern concept and basic data derived from human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

SSRIs antidepressant activity is influenced by G beta 3 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Serotonin and hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

New antidepressant drugs that do not cross the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Fluoxetine increases the content of neurotrophic protein S100beta in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Antidepressants induce regeneration of catecholaminergic axon terminals in the rat cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Reduced serotonin release and serotonin uptake sites in the rat nucleus accumbens and striatum after prenatal cocaine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Conditioned-fear stress increases Fos expression in monoaminergic and GABAergic neurons of the locus coeruleus and dorsal raphe nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940403500112

10.1177/155005940403500112

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference